Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease

Alzheimer Disease Clinical Trial

— UPLIFT-AD  

Official title:

Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04520698
• Other study ID #: 2005967061
• Secondary ID: R01AG066922
• Status: Recruiting
• Phase: N/A
• Start date: September 8, 2021
• Est. completion date: September 2025

Study information

• Verified date: March 2024
• Source: Indiana University
• Contact: Alex Floyd
• Phone: (317) 274-9164
• Email: acfloyd[@]regenstrief.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate a comprehensive model for integrating both primary and specialty Palliative Care for older adults with dementia into nursing facilities. Palliative Care is a supportive care approach that aims to improve the quality of life of patients and their families facing serious or life-threatening illnesses, through the prevention and relief of suffering through the treatment of pain and other problems, using physical, psychosocial and spiritual approaches. Palliative care is specialized medical care for people who are living with a serious illness. This type of care is focused on providing relief from the symptoms and from the stress of the illness. The goal is to improve quality of life for both patient and family.

The UPLIFT-AD model will include providing education on primary Palliative Care for residents with dementia to nursing facility staff, training nursing facility staff in providing primary Palliative Care, and providing access to specialty Palliative Care consultations for residents. To help understand the impact of these interventions, this study will also collect information about resident health, the care they receive, and perceptions of their quality of life according to both family members and nursing facility staff.

Description:

The objective of this proposal is to evaluate the effectiveness of the UPLIFT-AD (Utilizing Palliative Leaders In Facilities to Transform care for Alzheimer's Disease) intervention and to assess the implementation context of the intervention using a hybrid 1 trial design. The UPLIFT-AD intervention includes 1) in-house PC champions trained to facilitate goals of care conversations with residents with Alzheimer's Disease and Related Dementias (ADRD) and their surrogate decision-makers, screen residents for symptoms and other PC needs, provide symptom management and serve as a liaison to external PC consultants; 2) specialty PC consultants who provide consults for complex residents and families; and 3) primary PC education for nursing home (NH) staff. The study will use a randomized, stepped wedge design involving 16 diverse NHs in Indiana and Maryland and 640 residents, 640 family members and/or surrogate decision-makers, and 320 nursing facility staff.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2000
• Est. completion date: September 2025
• Est. primary completion date: September 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

-

NURSING HOME RESIDENTS:

• Long-stay resident in an enrolled nursing home defined as not paying through Medicare Part A at the enrolled facility.

• Has a diagnosis of moderate to severe ADRD, as measured on the Minimum Data Set (MDS)

• Length of stay >30 days

FAMILY MEMBERS/SURROGATE DECISION MAKERS:

• Family member and/or surrogate decision maker for an eligible resident in an enrolled nursing home

• English-speaking

NURSING HOME STAFF:

• Staff, nurse, or nurse assistant in an enrolled nursing facility

• English-speaking

Exclusion Criteria:

-

NURSING HOME RESIDENTS:

• Short-stay resident, defined as paying through Medicare Part A at the enrolled facility and/or receiving respite care

FAMILY MEMBERS/SURROGATE DECISION MAKERS:

• Non-English-speaking

NURSING FACILITY STAFF:

• Non-English-speaking

Related Conditions & MeSH terms

• Alzheimer Disease

Intervention

Behavioral:
• UPLIFT-AD
Access to palliative care needs screening, advance care planning conversations, palliative care consultations

Locations

Country	Name	City	State
United States	American Senior Communities	Indianapolis	Indiana

Sponsors (3)

Lead Sponsor	Collaborator
Indiana University	National Institute on Aging (NIA), University of Maryland, Baltimore

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in End-of-Life Dementia - Comfort Assessment In Dying scale (EOLD-CAD)	The EOLD-CAD items assess the following 14 symptoms and conditions during the last 7 days of life: discomfort, pain, restlessness, shortness of breath, choking, gurgling, difficulty in swallowing, fear, anxiety, crying, moaning, serenity, peace, and calm. These signs are assessed on a scale ranging from 1 to 3 as follows: not at all, somewhat, and a lot. The last 3 items are reverse-coded because they are considered good conditions. The CAD-EOLD score is constructed by summing the value of each item, and the total score ranges from 14 to 42 with higher scores indicating better symptom control.	1, 6, 12, and 18 months
Secondary	Change in End of Life Dementia - Satisfaction with Care (EOLD-SWC) scale	The EOLD-SWC assesses satisfaction with care during the prior 7 days. The EOLD-SWC has 10 items, each measured on a 4-point Likert scale ranging from 1 to 4 as follows: strongly disagree, disagree, agree, strongly agree. The questionnaire items address decision-making, communication with health care professionals, understanding the resident's condition, and the resident's medical and nursing care. The total EOLD-SWC score represents a summation of all 10 items (range, 10-40), with higher scores indicating more satisfaction.	6, 12, and 18 months
Secondary	Change in Single item quality-of-life (QOL) measure	The single item quality-of-life measure is a seven point scale describing overall quality of life. Lower scores indicate poorer quality of life.	1, 6, 12, and 18 months
Secondary	Change in staff perceptions survey	Change in staff perceptions surrounding impact, adoption, and buy-in to the intervention will be assessed using a two-item survey that asks about the perceived helpfulness of interactions and materials provided to residents and families.	6, 12, and 18 months
Secondary	Change in Palliative Care outcomes	Change in nursing home-level palliative care outcomes will be assessed using abstraction from the Minimum Data Set, and include measures of resident mood, pain and symptom management, hospice use, goals of care, and palliative care service use.	1, 3, 6, 9, 12, 15, and 18 months
Secondary	Change in staff palliative care knowledge	Change in staff palliative care knowledge will be measured by the Palliative Care survey (PCS). The PCS is a validated instrument, which includes subscales evaluating the frequency of key PC practice behaviors: family communication, provider coordination, planning/intervention, and bereavement. The total instrument score and each of the subscales are averaged to produce a range from 1 to 4, with higher scores indicating superior PC practices.	5 and 7 months
Secondary	Quality of Dying in Long Term Care (QOD-LTC)	The quality of dying-long-term care (QOD-LTC) was developed for cognitively impaired and intact residents in NHs and residential care/assisted living settings [21]. It assesses perspectives on quality of personhood, closure, and preparatory tasks. Higher mean scores reflect a higher quality of end-of-life in LTC.	18 months
Secondary	Fidelity to intervention	The UPLIFT fidelity checklist evaluates whether core components of UPLIFT have been sufficiently implemented at both the facility and resident level. Facility level components include: receipt of staff training; establishment of a facility tailored UPLIFT protocol manual; identification of at least two in-house champions; assigned external PC consultants.	1, 6, 12, and 18 months
Secondary	Change in Family Distress in Advanced Dementia Scale.	The Family Distress in Advanced Dementia Scale was developed for use with family members of nursing home residents with advanced dementia. This 21-item scale consists of three domains of distress: emotional distress, dementia preparedness, and nursing home relations. Higher scores indicate higher distress.	6, 12, and 18 months
Secondary	Change in End of Life Dementia - Symptom Management Scale.	This scale examines the frequency a resident experiences nine symptoms a during the previous 7 days: pain, shortness of breath, depression, fear, anxiety, agitation, calm, skin breakdown, and resistance to care. Frequency is assessed using a 6-point Likert scale ranging from 0 to 5: daily, several days a week, once a week, 2 or 3 days a month, once a month, never. The EOLD-SM score ranges from 0-45 with higher scores indicating better symptom control (comfort).	1, 6, 12, and 18 months